MedTrace Logo

Evaluation of Gender-Affirming Treatments on Pulmonary Function in Transgender and Gender Diverse Patients

NCT05587751 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2026-05-18

No results posted yet for this study

Summary

The purpose of this research study is to evaluate whether undergoing gender affirming care will impact the way the lungs function.

Conditions

  • Hormonal Gender-Affirming Therapy

Interventions

DIAGNOSTIC_TEST

Spirometry

Pulmonary function test to measure lung function

DIAGNOSTIC_TEST

Plethysmography

Pulmonary function test to measure lung volume

Sponsors & Collaborators

Principal Investigators

  • Gustavo Cortes Puentes, MD · Mayo Clinic

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-01
Primary Completion
2027-07-31
Completion
2027-07-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05587751 on ClinicalTrials.gov